Patient Experiences Initiating Continuous Subcutaneous Apomorphine Infusion (CSAI): An Interview-based Survey of InfusON Study Participants (P11-5.029)
Obtain Parkinson’s disease (PD) patient feedback on experiences initiating and using continuous subcutaneous apomorphine infusion (CSAI).
Authors
- Mindy Grall
- Pinky Agarwal (ORCID: https://orcid.org/0000-0002-1219-1735)
- Nikkilina Crouse
- A. Breiteneicher
Institutions
- Supernus Pharmaceuticals (United States) (US)
- Evergreen Health Medical Center (US)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000211253
- Primary Topic
- Botulinum Toxin and Related Neurological Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00